Telemedicine – medicolegal issues and answers: an update article
Leon G Tong 唐力安, Billy CF Chiu 趙志輝, David KF Kan 簡錦輝
HK Pract 2021;43:96-101
Summary
Many countries have been adversely affected by
the on-going COVID-19 pandemic to the extent of
having to endure complete or major lockdowns of their
medical services for various periods and durations,
including the closing of their local community clinics.
In those places, Telemedicine was not merely just
an alternative choice, but often has become the only
means of consultation for patients with their doctors.
In contrast, Hong Kong which is primarily an urban
locale with excellent and easy physical access to both
Private and Public clinics. It has been fortunate in not
having to undergo complete or major lockdowns due to
the COVID-19 pandemic, and that most doctors’ offices
have remained open throughout this period. The hope
is that this will remain the case despite recent surges.
Even so, Telemedicine (or interest in it) may be on
the ascendant, due to various factors. Telemedicine
has many advantages; it will be useful in cross-border
situations, especially when travel restrictions are in
place. Telemedicine will help to reduce cross-infection,
and many doctors are terrified that their offices may
be forced to close if a patient or staff is deemed as
positive or a “close contact”. Patients have also been
reluctant to attend in person to doctors’ offices due to
the fear of being exposed, so having at least the option
of being able to offer patients telemedicine services
is certainly something to know about. This can be
done using the doctor’s own or other public platforms,
or perhaps less desirably, patronising commercial or
business companies offering brokered services who
supply their own list of patients.
摘要
許多國家因受到持續全球性COVID-19大流行影響,需要暫停包括社區醫療等各種服務。在這些地區,遙距醫療不僅是另類選擇,而是與病人診症的唯一途徑。相比其他地區,香港具備優良的交通網絡,病人可以輕易地前往私人或公營診所求診。幸好,香港未因疫情而需要全面或大規模封城。多數醫生仍然繼續應診。冀望這種情況不會受到近日確診人數上升而改變。即使如此,遙距醫療(或對它的興趣)可能會由於不同因素而漸趨普及。對誇境人士而言 ,尤其是當交通往來受到限制時,遙距診症變得至為重要。遙距診症亦有助減低交叉感染風險。很多執業醫生害怕其病人或同事一旦被確診或界定為“緊密接觸者”時,他們的醫務所會被強制停診。亦有病人擔心受到感染而不願親身前往診所求診。無論如何,我們至少已意識到為病人提供遙距醫療服務的可能性。醫生可以使用自己的平台或在其他公共平台操作。或較為欠理想的,可為一些商營中介公司所提供的病人服務。本文簡列一些家庭醫生在開拓遙距醫療服務時需要考慮的問題。
Introduction
A webinar1 focusing on the practicaland medicolegal aspects of
Telemedicine was hosted in
October 2020 by The Hong Kong College of Family
Physicians (HKCFP) in partnership with the Medical
Protection Society (MPS). This topic was chosen due to
a perceived rise in interest in telemedicine as evidenced
by a rise in enquiries to MPS on this topic, its increased
use overseas and the start-up of a few commercial telemedicine platforms in Hong Kong
(HK). The
objective was not to promote nor discourage the role of
telemedicine but to discuss the medicolegal implications
of its use in relation to our MPS & HKCFP members.
Panel members included the Medical Director
of MPS, and the current authors of the article, in
their roles as MPS affiliated legal professionals and
moderators from the HKCFP Board of Education
An opinion poll1
was conducted amongst the
participants and many interesting questions were
raised. This article summarises and elaborates on points
discussed by the panel during the webinar, and also
provides additional information that was not covered
during the webinar.
(1) Participant polls1:
The webinar audience had a rather high 75%
participation rate of having done any form of
telemedicine in their practice. This could have been
as basic as conducting a consultation by telephone
up to perhaps a full remote video interview.
-
60% responded that they felt sufficiently
comfortable to practice more telemedicine.
-
74% had prescribed medication after a teleconsultation.
However, in contradiction to the above, 95%
of respondents believed that more telemedicine
training was required, and 88% wanted
regulatory updates on the rules and regulations
of telemedicine, showing that there was certainly
room for improvement in training and advice.
(2) Are there local guidelines on telemedicine?
The Medical Council of Hong Kong (MCHK)
published a timely “Ethical guidelines on practice
of telemedicine” in their December 2019 MCHK
Number 26 Newsletter which was sent out to
registered practitioners.2
It should be noted that
these are guidelines to what the expected standard
is, and not rules set out in stone, which is an
appropriate approach to address this rapidly
evolving area.
With regards to the issue of jurisdiction, a
doctor must comply with the law governing the
practice of medicine in the jurisdiction where the patient receives the medical
services.2
If necessary,
the doctor may consider liaising with a local doctor
where the patient is situated to overcome this
problem.3
(3) What is the definition and scope of telemedicine?
The MCHK guideline has adopted the
World Medical Association (WMA) definition of
telemedicine and such definition was amended in
the October 2018 WMA Statement2:
“…the practice of medicine over a distance,
in which interventions, diagnoses, therapeutic
decisions, and subsequent treatment
recommendations are based on patient data,
documents and other information transmitted
through telecommunication systems.”
Furthermore ,in the MCHK Guideline2,
telemedicine included but was not limited to:
“(a) tele-treatment of patients within the definition
of WMA;
(b) collaboration between doctors and/or with
other healthcare professionals through
telecommunication systems;
(c) monitoring of patients through
telecommunication systems; and
(d) dissemination of service information and/
or health education to the public (including
patients) through telecommunication systems.”
Therefore, the scope of telemedicine embraces
a wide spectrum of activities which medical
practitioners should be familiar with before using it
in their clinical practice.
(4) What technology is appropriate to conduct telemedicine?
The technology must be fit for its purpose
including system stability and encryption for data
protection.
In the MCHK guideline2 :
“telecommunication
systems include telephone, email, social media
(e.g. SMS, WhatsApp, Facebook, internet forum &
etc.); and other means of electronic communication
between two or more people in different locations,
at least one of which is within Hong Kong.”
All doctors should receive proper training in
the operation of whichever application is being
used.
(5) What should I (the doctor) explain to the patient
if I (the doctor) want to obtain an informed
consent?
The patient needs to be given a full
explanation on how telemedicine works, its
limitations, suitable alternatives, privacy concerns,
the possibility of technological failure including
confidentiality breaches, prescribing policies and
the coordination of care with other healthcare
professionals5
.
Although a doctor may rely on implied
consent, it is advisable to obtain an express consent
from the patient and incorporate the documentation
into the process of telemedicine delivery. The
process includes the patient’s understanding on
the reason for an online instead of a face-to-face
consultation, their agreement to proceed with that
particular mode or platform, and identity of all
parties, as well as how privacy will be safeguarded.5
A standardised form, perhaps to be formulated
in the future, would facilitate this process.
(6) What should be documented in my (doctor’s)
records after a teleconsultation?
The minimal content requirement would be
the same as in a face-to-face consultation, and
additional information will need to be documented4.
This includes:
(a) A proper record on the information received
and advice delivered.
(b) The clinical history and other information
received including video observations and
investigation results.
(c) A detailed documentation of the options
discussed, including an option of no treatment
or refusal to proceed, should be carefully
explained. If there is a termination of a
teleconsultation and a conversion to a face-to-face appointment, this must also be
recorded.
(d) Furthermore, it is vital to record a safety
net if the patient’s condition does not show
improvement, with a clear written instruction
for further assessment and follow-up care.
(e) If video recording is considered, documentation
of a patient’s agreement is required.
(f) Obviously, in addition to written records, a
video recording of the consultation would
provide additional support to demonstrate that
a proper consultation was conducted.
(g) The reasons as to why a face-to-face consultation
was not done as the first choice.9
(7) Can I (the doctor) prescribe medicine after a
teleconsultation with a patient in HK?
The doctor must evaluate if all required clinical
information obtained through the teleconsultation
satisfies his/her usual criteria for prescription and
that such practice is comparable to the doctor’s
face-to-face consultation.2
Furthermore, the doctor
will need to fulfil the clinic nurse’s or the hospital
pharmacist’s role in explaining and documenting
the patient’s understanding of the instructions for
administration of the medicine.
(8) Can a patient’s representative pick up the
medicine at the clinic on behalf of the patient?
A common scenario is that of a patient
requesting a proxy or representative such as a
relative to pick up their medicine at the clinic
on the patient’s behalf. There is no such express
provision or regulation in Hong Kong, and it
is recommended that medicine is issued only if
the doctor is satisfied with the representative's
identity, by way of an authorisation letter and
keeping a record of the representative's HKID or
other identification in the patient's records. If the
doctor decides to allow a representative to pick
up a patient’s “Dangerous Drug”, extra-vigilance,
say, in the way of a recorded confirmation with the
patient when the representative arrives at the clinic
is advisable.
(9) Can I electronically send a prescription to the patient
to obtain the medicine from a community pharmacy?
If a doctor is satisfied with the teleconsultation
and decides to prescribe to the patient, the doctor
may send a copy of the prescription by fax or
email in advance, but the patient must provide the
originally signed prescription upon picking up the
medicine at the community pharmacy.
(10) Should I entertain the patient’s requests for the
delivery of medicine to the patient’s home?
For delivery of medicine, again there is no
express provision for or against this method by an
intermediary. The doctor should ensure the integrity
of the delivered medicine, so that there are no mix-ups, and to ensure that the quality
of the medicine
is not adversely affected. Delivery of Dangerous
Drugs by an intermediary must be avoided.
(11) What if the patient is based in Mainland China or
Macau, can I dispense and supply medicine?
Regarding delivery or supplying medicine to
patients outside of Hong Kong, currently, there is a
special scheme initiated by the Government of Hong
Kong Special Administrative Region (HKSAR)
to deliver prescription medicine to HK residents
with urgent needs in Guangdong and Fujian8
.
Apart from this scheme, repeating a
prescription to an existing patient suffering from
a chronic condition should be acceptable provided
that the patient’s condition has been stable and
the previously mentioned jurisdictional issues are
taken into account. It is probably not advisable to
provide a large supply of medicine and the doctor
will need careful documentation.
(12) In the event of a complaint or claim from an
international patient following a telemedicine
services, in which jurisdiction is it likely to be
pursued? And am I protected by the MPS?
In order to satisfy the MCHK dual
jurisdictions’ licensing guideline, a doctor must
have a valid practicing license in both countries
(e.g. both in Hong Kong and the People’s Republic
of China), if he intends to undertake the consultation
solely on his/her own
When a Hong Kong doctor without dual
licensing provides a second opinion service in
a joint consultation with the patient and his/her
Mainland doctor, the Hong Kong doctor must
clearly document their role of interpreting the
limited clinical information of the patient. In the
case of an adverse event, the patient may proceed
to make a complaint or claim against a doctor either
in Hong Kong or the People’s Republic of China.
It has been the experience of the MPS that
claims are usually brought to and made in the
jurisdiction in which the doctor is domiciled
(i.e. lives in and usually practises), as this is
most likely where a judgement can be enforced
against the doctor, but this is not a given. MPS
will support its members based on the rules and
regulations of the member’s domicile location
(i.e. where he is listed as a member) and will be
protected in a claim made to the member in HK.
(13) What are the considerations for a doctor when
participating in a Commercial or Business entity
telemedicine platform, which advertises an online
doctor’s service?
The COVID-19 pandemic has accelerated the
development of mobile Apps as online platforms for
new patients to remotely ask questions about their
symptoms. Given the clinical context, is the doctor
satisfied that there will be proper evaluation? It
is advisable that the patient has had prior in-person consultation, such that the doctor
already
has knowledge of the patient's identity, medical
history and access to previous medical records.9
It is important that the patient is not "short-changed” due to the doctor only having
incomplete
or inaccurate information. If physical examination
is likely to add critical information, then the doctor
should not proceed until an examination can be
arranged.10 A doctor is recommended to consider
his/her participation as a “Panel Doctor” with
caution. He/she must understand the circumstances
in which a new patient is referred, the risk of
breaching practice promotion (advertising) rules
and possible improper financial transactions. It
is of the utmost importance to remember that the
online service companies simply act as business
brokers or middle-men between the doctors and
their patients, and that it is ultimately the doctors
themselves who are held professionally accountable
and answerable to the Medical Council.
(14) Which type of patients are appropriate for
practicing telemedicine?
As discussed above, it is advisable that the
patient is an existing known patient of the doctor.
Doctors must be aware that a “doctor-patient
relationship” is the cornerstone of providing patient care. Due diligence is needed to
ensure that the
true identity of both the doctor and patient can be
verified to all parties during a remote consultation,
such as by providing photo identification at the
time of a video consultation.
Otherwise it really depends on the
circumstances of the consultation. Telemedicine
can be especially useful where it is difficult or
inadvisable for the patient to attend to the doctor
in-person, whether to minimise infection risks
or due to other factors such as poor mobility10.
Documentation is needed as to the reason a face-to-face consultation is
inappropriate9
Note that the MCHK still views that the
Standard of Care that is given during a person-to-person consultation must apply equally
to a
Telemedicine consultation. Obviously, telemedicine
is appropriate only if the medical condition can
be managed without needing a full “hands-on”
physical examination. Generally, follow-ups of
chronic or established conditions will be easier
to manage remotely than compared to, say, new,
undiagnosed or undifferentiated symptoms.
However, the correct interval between remote
visits until the time an in-person consultation
becomes necessary will depend on factors such as
whether any significant change in clinical condition
is expected, or if there will be a significant change
in medication or dosage, and will rely on each
doctor’s individual clinical judgement. There may
even be added benefits for some specialties such
as rheumatology patients for whom it may be
inconvenient to travel to the clinic, whereby the
doctor can observe functional ability of the patient
in real time in his home environment. From
previous Hospital Authority experience, geriatric
and psychiatric services may also be amenable to
telemedicine follow up.
(15) How should I follow up with the patient after a
teleconsultation?
This is one of the commonest “weakest links”
in medico-legal cases.9
The doctor must clarify
with the patient as well as with other healthcare
professionals involved what their respective roles
and follow-up responsibilities are for a successful
continuity of care of the patient.8
Written instruction should be given to the patient on what
warning symptoms to look out for, how and when
the doctor can be contacted later, and the steps
the patient should take if he/she is unsuccessful in
contacting the doctor.
(16) How can I manage the medicolegal risks of
patients’ remote monitoring?
In the World Medical Association definition,
“Monitoring of patients through telecommunication
systems”, is a form of telemedicine. The ability
to remotely monitor their patient’s urgent medical
data and events is an area of increasing interest
to primary care physicians. This can range from
simple tasks such as having patients taking and
reporting their own periodic blood pressures or
serum glucose levels to more complex methods
such as Telemetric Holter ECG
Furthermore, the COVID-19 pandemic has
driven the global adaptation of remote monitoring
to triage patients with chronic disease to their
appropriate least frequent interval of face-to-face follow-up. Despite research showing
higher
patient satisfaction and quality of life after using
telemedicine11, many doctors are reluctant to
adopt Remote Patient Monitoring (RPM) because
of the fear of liability. Possible pitfalls include the
continual alerts, calls or failed contacts that may
not be properly handled by clinic staff despite their
best efforts.
Finally, the issues of data accuracy and
security cannot be overlooked6
. Therefore, good
clinic protocols and policies of how to interpret and
handle incoming data from RPM will need to be
established, before RPM can be used for effective
and accurate patient care.
(17) Finally, what are the major areas of pitfalls in
Telemedicine that one should remember?
To recap, the issues in general that require
particular attention are:
(i) adequate verification of identity of both parties;
(ii) increased difficulty in establishing a trustful
doctor-patient relationship;
(iii) possible inherent problems with technology
relating to its use, storage and privacy;
(iv) a remote physical examination may be less
comprehensive and reliable than a “hands-on”
examination; and
(v) lastly, whatever problems and requirements that
apply to person-to-person consultations will also
apply to consultations made by telemedicine.
Conclusion
In conclusion, it seems there is an urgent need
to establish an appropriate telemedicine training
programme locally for Hong Kong doctors in order
increase their confidence level, even if they may
have already adopted it or have decided to do so in
the future. There are numerous medicolegal pitfalls
in telemedicine, and it is only by having a critical
understanding and review of the issues at the heart of
this matter so that a doctor will be able to navigate
safely through these challenges.
The MPS is delighted to be in continuous
conversation with the HKCFP in order to pique our
doctors’ interest towards adopting Telemedicine by
providing educational articles such as this one, or
perhaps by implementing a future training programme
for the benefit of our respective members and fellows.
For those who may be interested, several webinars on
Telemedicine may additionally be viewed on the MPS’
website.12
The authors welcome further discussions on this topic.
Disclaimer:
This article presents material that has
been prepared in good faith by the current authors
and members of the webinar panel which included the
Medical Director of the Medical Protection Society
(UK), lawyers from one of the MPS’s appointed legal
practices in HK, MPS’s HK Medicolegal Consultant
and moderators from the HKCFP Board of Education.
However, the material must not be taken as definitive
legal advice and readers are advised to obtain specific
legal advice from their respective medical defense
organisations or legal professionals if necessary.
Leon G Tong, MBBS (HK), CCFP, FCFP
Private Family Physician and Member,
Board of Education, The Hong Kong College of Family Physicians
Billy CF Chiu, MBBS (HK), MPH (HK), FRACGP, FHKAM (Family Medicine)
Associate Professor of Practice in Family Medicine,
Faculty of Medicine, The Chinese University of Hong Kong
David KF Kan, BMBS, Solicitor Advocate
Partner,
Howse Williams
Correspondence to: Dr. Billy CF Chiu / Dr Leon G Tong c/o
Gleneagles Hospital HK,
1 Nam Fung Path, Wong Chuk Hang, Hong Kong SAR.
E-mail: billy.chiu@gleneagles.hk
References:
-
The Hong Kong College of Family Physicians. Online Seminar: Medico-legal
webinar for HKCFP - telemedicine in family practice. [cited 2020 Dec 15].
-
Guidelines for all registered medical practitioners. The Medical Council of
Hong Kong Newsletter; 2019 Dec 26. [cited 2020 Dec 10]. Available from:
https://www.mchk.org.hk/files/newsletter-26th.pdf
-
Medical Protection Society. COVID-19 and remote consultations – how we
can help. 16 March 2020. [cited 18 Dec 2020].
-
MPS welcomes HPCSA Guidelines on telemedicine. Medical Protection
Society. 2020 April 7. [cited 2020 Dec 18].
-
Schallhorn SC, Hannan SJ. Informed consent in refractive surgery: in-person
vs telemedicine approach. Clin Ophthalmol. 2018;12:2459-2470.
-
Benefit of remote consultations is unquestionable, but challenges must be
considered. Medical Protection Society. 2020 July 30. [cited 2020 Dec 18].
-
South Africa doctors see benefits of telemedicine – though 9 in 10 concerned
some patients may get left behind. Medical Protection Society. 2020
December 17. [cited 2020 Dec 18].
-
Special scheme introduced for delivering prescription medications to Hong
Kong people in Guangdong and Fujian with urgent need for medications,
HKSAR. Available from: https://www.info.gov.hk/gia/general/202002/24/
P2020022400501.htm
-
Becker C, Dandy K, Gaujean M, et al. Legal perspectives on telemedicine
part 1: legal and regulatory issues. Perm J. 2019;23:18-293.
-
AMA adopts new guidance on ethical practice in telemedicine Chicago, IL:
American Medical Association; 2016 Jun 13. [cited 2020 Dec 20]. Available
from:
http://www.ama-assn.org/ama-adopts-new-guidance-ethical-practice-telemedicine
-
Volterrani M, Sposato B. Remote monitoring and telemedicine. European
Heart Journal Supplements. 2019 Dec;21(Suppl M):M54-M56
-
Digital future, tele consultation webinar. Medical Protection Society.
Available from: https://www.medicalprotection.org/ireland/digitalfuture/
telemedicine
|